home / stock / krys / krys news

KRYS News and Press, Krystal Biotech Inc. From 09/22/23

Stock Information
Company Name: Krystal Biotech Inc.
Stock Symbol: KRYS
Market: NASDAQ
Website: krystalbio.com
Menu
KRYS KRYS Quote KRYS Short KRYS News KRYS Articles KRYS Message Board
Get KRYS Alerts

News, Short Squeeze, Breakout and More Instantly...
KRYS - Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement

2023-09-22 09:54:38 ET Summary Krystal Biotech, Inc. received FDA approval of Vyjuvek, for the treatment of patients with dystrophic epidermolysis bullosa in May of 2023. FDA IND clearance of KB408 for the treatment of patients with antitrypsin deficiency given; Phase 1 study expe...
KRYS - Krystal Biotech wins FDA nod to run trial for gene therapy

2023-09-21 13:20:11 ET More on Krystal Biotech Seeking Alpha’s Quant Rating on Krystal Biotech Financial information for Krystal Biotech Krystal Biotech: Pioneering Rare Disease Gene Therapies Berenberg starts Krystal Biotech at buy, cites upcoming dru...

KRYS - Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency

• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of genetic med...

KRYS - Krystal Biotech CEO sells shares worth $6.3M

2023-09-13 06:31:15 ET More on Krystal Biotech Seeking Alpha’s Quant Rating on Krystal Biotech Historical earnings data for Krystal Biotech Berenberg starts Krystal Biotech at buy, cites upcoming drug launch Krystal Biotech IND application for solid tu...
KRYS - Berenberg starts Krystal Biotech at buy, cites upcoming drug launch

2023-09-07 18:03:10 ET More on Krystal Biotech Seeking Alpha’s Quant Rating on Krystal Biotech Historical earnings data for Krystal Biotech Financial information for Krystal Biotech Krystal Biotech: Pioneering Rare Disease Gene Therapies Krysta...

KRYS - Krystal Biotech to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

PITTSBURGH, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, ann...

KRYS - Krystal Biotech gets FDA orphan drug designation for AATD drug candidate

2023-09-05 11:40:20 ET More on Krystal Biotech Seeking Alpha’s Quant Rating on Krystal Biotech Historical earnings data for Krystal Biotech Financial information for Krystal Biotech Krystal Biotech: Pioneering Rare Disease Gene Therapies Krysta...
KRYS - Krystal Biotech Announces Orphan Drug Designation Granted to KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

KB408 IND filed on August 15, 2023 PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to tr...

KRYS - Krystal Biotech announces sale of priority review voucher for $100 million

2023-08-21 07:31:33 ET More on Krystal Biotech Krystal Biotech: Pioneering Rare Disease Gene Therapies Seeking Alpha’s Quant Rating on Krystal Biotech Earnings data for Krystal Biotech For further details see: Krystal Biotech announces sale of prio...

KRYS - Krystal Biotech Announces Sale of Priority Review Voucher for $100 Million

PITTSBURGH, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs, announced t...
Previous 10 Next 10